Multinazionale Farmaceutica specializzata nella produzione di Farmaci Sterili Iniettabili conto terzi Sei un Laureato/a in materie scientifiche motivato/a a maturare esperienza in un contesto di produzione farmaceutica dove poter sviluppa...
for managing and controlling all project documentation, ensuring that accurate and up-to-date information is available to the..., distribution, and tracking of all incoming and outgoing project documentation, including drawings, specifications, contracts...
Solve detected problems implementing the needed correction Documentation Prepare and maintain software documentation... in accordance company and industry standard Generate reports and documentation for regulatory compliance Collaboration...
while also dealing with legal-commercial matters, such as supply agreements, pre-contractual documentation, and the management... documentation, including letters of intent, memoranda of understanding, and binding offers. Coordinate and assist in the...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »